Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early Changes in Eosinophil Cationic Protein and Sputum Eosinophils Following Subcutaneous Allergen Immunotherapy in Allergic Asthma
NCT07694947Completed
- Sponsor
- Mansoura University Hospital
- Start
- Jan 2023
- Primary completion
- Jul 2023
- Countries
- 1
01
Overview
Open-label, single-arm trial of Allergen Immunotherapy Extract in allergic asthma, sponsored by Mansoura University Hospital. Primary endpoint: Clinical response at 6 months. Started Jan 2023; status: completed.
02
Drugs
Allergen Immunotherapy Extract
03
Conditions
allergic asthma
Beyond the preview
Go deeper on NCT07694947.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07694947.